amoxicillin (750 mg), clarithromycin (200 mg), and either esomeprazole (20 mg) (EAC group), twice a day for one week.	amoxicillin (750 mg), clarithromycin (200 mg), and rabeprazole (10 mg) (RAC group), twice a day for one week.	H. pylori eradication	9662	10011	The eradication rates of the EAC and RAC regimen groups were 79.8% [95% confidential interval (CI): 71.7-89.0%] and 74.7% (66.0-83.4%) for the per protocol (PP) analysis and 75.8% (67.4-84.2%) and 71.0% (62.1-79.9%) for the intention-to-treat (ITT) analysis, respectively (Fig. 2A). No significant differences were observed between the two regimens.
amoxicillin (750 mg), clarithromycin (200 mg), and either esomeprazole (20 mg) (EAC group), twice a day for one week.	amoxicillin (750 mg), clarithromycin (200 mg), and rabeprazole (10 mg) (RAC group), twice a day for one week.	H. pylori eradication	931	1288	The eradication rates of the EAC and RAC regimens were 79.8% (95% confidential interval: 71.7-89.0%) and 74.7% (66.0-83.4%), respectively, in a per protocol (PP) analysis (p=0.488). The eradication rates of the EAC and RAC regimens were not significantly different between patients with the homo EM genotype (p=0.999) or hetero IM or PM genotypes (p=0.286).
amoxicillin (750 mg), clarithromycin (200 mg), and either esomeprazole (20 mg) (EAC group), twice a day for one week.	amoxicillin (750 mg), clarithromycin (200 mg), and rabeprazole (10 mg) (RAC group), twice a day for one week.	Eradication of H. pylori with homo EM genotype and those with hetero IM or PM genotype.	1113	1288	The eradication rates of the EAC and RAC regimens were not significantly different between patients with the homo EM genotype (p=0.999) or hetero IM or PM genotypes (p=0.286).
amoxicillin (750 mg), clarithromycin (200 mg), and either esomeprazole (20 mg) (EAC group), twice a day for one week.	amoxicillin (750 mg), clarithromycin (200 mg), and rabeprazole (10 mg) (RAC group), twice a day for one week.	Eradication of H. pylori with homo EM genotype and those with hetero IM or PM genotype.	10423	10887	The eradication rate of the EAC and RAC regimens in the homo EM patients was 73.3% (CI: 57.5-89.1%) and 76.7% (CI: 61.6-91.8%), respectively. In the hetero IM and PM patients, the eradication rate of the EAC regimen was 82.8% (73.6-92.0%), and that of the RAC regimen was 73.8% (63.1-84.5%). The eradication rates of the EAC and RAC regimen groups were not significantly different between the patients with homo EM genotype and those with hetero IM or PM genotype.
